Follow
Martin Tammemagi
Martin Tammemagi
Professor of Epidemiology, Brock University
Verified email at brocku.ca
Title
Cited by
Cited by
Year
The national lung screening trial: overview and study design
National Lung Screening Trial Research Team
Radiology 258 (1), 243-253, 2011
13122011
Probability of cancer in pulmonary nodules detected on first screening CT
A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ...
New England journal of medicine 369 (10), 910-919, 2013
12932013
Selection criteria for lung-cancer screening
MC Tammemägi, HA Katki, WG Hocking, TR Church, N Caporaso, ...
New England Journal of Medicine 368 (8), 728-736, 2013
9072013
Overdiagnosis in low-dose computed tomography screening for lung cancer
EF Patz, P Pinsky, C Gatsonis, JRD Sicks, BS Kramer, MC Tammemägi, ...
JAMA internal medicine 174 (2), 269-274, 2014
8292014
Targeting of low-dose CT screening according to the risk of lung-cancer death
SA Kovalchik, M Tammemagi, CD Berg, NE Caporaso, TL Riley, M Korch, ...
New England Journal of Medicine 369 (3), 245-254, 2013
5882013
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force
HJ De Koning, R Meza, SK Plevritis, K Ten Haaf, VN Munshi, J Jeon, ...
Annals of internal medicine 160 (5), 311-320, 2014
5192014
Comorbidity and survival disparities among black and white patients with breast cancer
CM Tammemagi, D Nerenz, C Neslund-Dudas, C Feldkamp, ...
Jama 294 (14), 1765-1772, 2005
4652005
Smoking and lung cancer survival: the role of comorbidity and treatment
CM Tammemagi, C Neslund-Dudas, M Simoff, P Kvale
Chest 125 (1), 27-37, 2004
3412004
Impact of comorbidity on lung cancer survival
CM Tammemagi, C Neslund‐Dudas, M Simoff, P Kvale
International journal of cancer 103 (6), 792-802, 2003
3362003
Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts
MC Tammemaegi, TR Church, WG Hocking, GA Silvestri, PA Kvale, ...
PLoS medicine 11 (12), e1001764, 2014
3352014
Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation
CM Tammemagi, PF Pinsky, NE Caporaso, PA Kvale, WG Hocking, ...
Journal of the national cancer institute 103 (13), 1058-1068, 2011
3232011
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
GY Jin, D Lynch, A Chawla, K Garg, MC Tammemagi, H Sahin, S Misumi, ...
Radiology 268 (2), 563-571, 2013
2812013
Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study
K Ten Haaf, J Jeon, MC Tammemägi, SS Han, CY Kong, SK Plevritis, ...
PLoS medicine 14 (4), e1002277, 2017
2722017
Impact of lung cancer screening results on smoking cessation
MC Tammemägi, CD Berg, TL Riley, CR Cunningham, KL Taylor
Journal of the National Cancer Institute 106 (6), dju084, 2014
2212014
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
MC Tammemagi, H Schmidt, S Martel, A McWilliams, JR Goffin, ...
The lancet oncology 18 (11), 1523-1531, 2017
2042017
Long-term prognostic role of functional limitations among women with breast cancer
D Braithwaite, WA Satariano, B Sternfeld, RA Hiatt, PA Ganz, ...
Journal of the National Cancer Institute 102 (19), 1468-1477, 2010
1642010
Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients
D Braithwaite, CM Tammemagi, DH Moore, EM Ozanne, RA Hiatt, ...
International Journal of Cancer 124 (5), 1213-1219, 2009
1442009
Performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting: a microsimulation modeling analysis in Ontario, Canada
K Ten Haaf, MC Tammemägi, SJ Bondy, CM van der Aalst, S Gu, ...
PLoS medicine 14 (2), e1002225, 2017
1432017
In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival
CM Tammemagi, C Neslund-Dudas, M Simoff, P Kvale
Journal of clinical epidemiology 57 (6), 597-609, 2004
1432004
The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency
S Cressman, SJ Peacock, MC Tammemägi, WK Evans, NB Leighl, ...
Journal of Thoracic Oncology 12 (8), 1210-1222, 2017
1392017
The system can't perform the operation now. Try again later.
Articles 1–20